Abstract

A number of recent studies indicate that many cancers express receptors for advanced glycation end products (RAGEs), and that stimulation of these receptors make these cancers more invasive and, in some cases, boosts their proliferation. In some of these cancers, autocrine production of protein agonists for RAGE (HMGB1, S1100A) promotes their spread; the typically aggressive growth of cancers in diabetics may reflect activation of RAGE by endogenously produced advanced glycation end products (AGEs). But RAGE can also be activated by dietary “glycotoxins” – compounds produced by Maillard reactions in highly heated foods that are structurally and functionally similar to AGEs produced in diabetics. In rodents, dietary glycotoxins promote oxidative stress and pathologies linked to oxidative stress, presumably via RAGE activation. These considerations suggest that low-glycotoxin diets may have potential for slowing the spread of certain cancers expressing RAGE, a proposition that can readily be tested in rodent tumor models. Guidelines for achieving such diets have been published; low-fat foods of plant origin are typically low in glycotoxins, and the glycotoxin content of animal products and fatty plant products can be minimized by cooking at low heat (e.g. boiling, steaming). It may also be feasible to suppress the downstream signaling of RAGE in cancers by inhibiting the activity of NADPH oxidase, which appears to be the chief source of the oxidative stress triggered by RAGE; a role for NADPH oxidase in the aggressive growth of many cancers has been established. By mimicking the physiological antioxidant role of free bilirubin, the phycocyanobilin richly supplied by spirulina has the potential to down-regulate NADPH oxidase activity, and thereby impede RAGE signaling.

Highlights

  • Recent studies have demonstrated that a wide range of cancers can express receptors for advanced glycation end products (RAGEs) receptors, and that stimulation of these receptors renders the cancer more aggressive – more invasive and, in some cases, more proliferative [1,2,3,4,5,6,7,8,9,10,11,12,13]

  • When chemotherapy kills cancer cells by necrosis, the resultant release of HMGB1 into the circulation may stimulate the growth of surviving cancer cells which express RAGE receptors [15]

  • Dietary Glycotoxin Content may Modulate the Growth of Rage-Expressing Cancers

Read more

Summary

Introduction

Recent studies have demonstrated that a wide range of cancers can express RAGE receptors (receptors for advanced glycation products), and that stimulation of these receptors renders the cancer more aggressive – more invasive and, in some cases, more proliferative [1,2,3,4,5,6,7,8,9,10,11,12,13]. Knock-down of RAGE expression, or administration of a soluble RAGE receptor (which opposes RAGE signaling by acting as a decoy) or of a RAGE antagonist, can slow cancer growth and spread [1,5,7,9,10]. Dietary Glycotoxin Content may Modulate the Growth of Rage-Expressing Cancers

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.